BLOOD-COAGULATION FACTOR VIII)(113189-02-9)
- Name: BLOOD-COAGULATION FACTOR VIII)
- Synonyms:AHF-A;Antihemophilic factor; Antihemophilic factor A; Antihemophilic globulin;Bioclate; Blood-coagulation factor VIII; Blood-coagulation factor VIIIc;Coagulation factor VIIIc; Cross Eight M; Factor VIII; Koate DVI; Monoclate;Monoclate-P; Octonativ-M; Procoagulant blood-coagulation factor VIII; Replenate
- Molecular Formula:
- Molecular Weight:0
- CAS Registry Number:113189-02-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.113189-02-9 BLOOD-COAGULATION FACTOR VIII)
Assay:99% Package:According to customer requirements Transportation:By Sea/Air/Courier Application:medicine
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)]
CAS No.113189-02-9 BLOOD-COAGULATION FACTOR VIII)
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)]
CAS No.113189-02-9 BLOOD-COAGULATION FACTOR VIII)
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:BLOOD-COAGULATION FACTOR VIII)
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
CAS No.113189-02-9 BLOOD-COAGULATION FACTOR VIII)
Assay:99.90% Appearance:solid or liquid Package:Foil bag; Drum; Plastic bottle Storage:in sealed air resistant place Transportation:by sea or air Application:Pharma;Industry;Agricultural
Min. Order:0
Supplier:Xi`an Eastling Biotech Co., Ltd. [
China (Mainland)]

Other Product
- 4483-08-3/Pyridoxamine-adenine dinucleotide
- 511-59-1/(1S-exo)-2-methyl-3-methylene-2-(4-methyl-3-pentenyl)bicyclo[2.2.1]heptane
- 33235-78-8/1-Butyl-2-(α-ethoxybenzyl)-2-imidazoline
- 141263-54-9/6-(2,4-dichlorophenyl)-erythro-2,4-dihydroxyhexylphosphonic acid
- 95-37-4/4,5-dihydro-2-undecyl-1H-imidazole-1-ethylamine
- 6045-27-8/methyl 2-(acetylamino)-5-[(1E)-1-cyanoprop-1-en-2-yl]-4-methylthiophene-3-carboxylate
- 95035-89-5/6,6-diethyl-1,4-diphenyl-1,4-diazepane-5,7-dione
- 7468-99-7/4-[Bis(phenylmethyl)amino]phenol
- 143563-20-6/21-[3,6-Dideoxy-3-[2-(dimethylamino)acetamido]-beta-D-mannopyranosyloxy]-N-[2-(dimethylamino)ethyl]-15,19-epoxy-3,7,9,11,13,15,17,41-octahydroxy-36,38-dimethyl-43-[4-(methylamino)phenyl]-5,43-dioxo-22(E),24(E),26(E),28(E),30(E),32(E),34(E)-tritetracontahe
- 69-79-4/Maltose
- 856-12-2/1-[2-(2-{2-[5-methyl-2-(propan-2-yl)phenoxy]ethoxy}ethoxy)ethyl]piperidine
- 5204-64-8/3-Pentenoic acid
- 107-30-2/Chloromethyl methyl ether
- 2016-37-7/undecan-1-amine hydrochloride (1:1)
- 7457-29-6/2-[2,2-bis(4-chlorophenyl)-1,3-dioxolan-4-yl]piperidinium chloride
- 92207-31-3/(E)-2-(4-ethoxy-2-methoxyphenyl)ethenyl (Z)-2-phenylethenyl sulfone
- 5445-68-1/2-[2-(diethylamino)ethyl]isothiourea monohydrochloride
- 302-41-0/piritramide
- 4301-57-9/3-(octadecyloxy)propane-1,2-diyl dimethanesulfonate
- 113189-02-9/BLOOD-COAGULATION FACTOR VIII)
- 30405-01-7/2-methylpropyl ethylmethylphosphinate
- 102071-05-6/N-cyclohexyl-4-methoxy-N-(2-piperidin-1-ylethyl)aniline dihydrochloride
- 103840-65-9/Piperazine, 1-(2-pyridinyl)-4-(3-(1-pyrrolidinyl)propyl)-, ethanedioate (1:3)
- 122576-59-4/26-deoxymonensin A
- 85392-00-3/2,3-Dihydro-2-methyl-1H-indol-1-amine monomethanesulphonate
- 3552-12-3/ethyl 11-cyclopent-2-enylundecanoate
- 79828-43-6/pentasodium bis[5-[(4-amino-6-chloro-1,3,5-triazin-2-yl)amino]-4-hydroxy-3-[(2-hydroxy-5-nitrophenyl)azo]naphthalene-2,7-disulphonato(4-)]chromate(5-)
- 94333-52-5/N-[2-[(2-cyanoethyl)amino]ethyl]-N-[2-(stearoylamino)ethyl]stearamide
- 134513-16-9/17-(4-bromobenzoyloxy)-9,11-epoxy-7-hydroxybeyerene
- 70844-20-1/3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 2,3,6-trideoxy-3-(dibenzylamino)hexopyranoside hydrochloride (1:1)